Dengue fever continues to prevail against all efforts of health-care systems: vector control programs against the mosquito vector Aedes aegypti, repellents and barrier inventions, education, and a vaccine touted with great expectations.
The Dengue vaccine has fallen short of promise: hundreds of adverse effects have been reported, a lack of efficacy to protect against the the most frequent viral serotype, and to boot, the threat that vaccine use can increase the severity of subsequent episodes There was much hue-and-cry from public health advocates and health care workers on the DOH’s “haste in the roll out of the vaccination campaign” for the Sanofi’s vaccine.